J. L. Kwiatkowski Et Al. , "Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study," BLOOD ADVANCES , vol.6, no.4, pp.1243-1254, 2022
Kwiatkowski, J. L. Et Al. 2022. Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study. BLOOD ADVANCES , vol.6, no.4 , 1243-1254.
Kwiatkowski, J. L., Hamdy, M., El-Beshlawy, A., Ebeid, F. S. E., Badr, M., Alshehri, A., ... Kanter, J.(2022). Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study. BLOOD ADVANCES , vol.6, no.4, 1243-1254.
Kwiatkowski, Janet Et Al. "Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study," BLOOD ADVANCES , vol.6, no.4, 1243-1254, 2022
Kwiatkowski, Janet L. Et Al. "Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study." BLOOD ADVANCES , vol.6, no.4, pp.1243-1254, 2022
Kwiatkowski, J. L. Et Al. (2022) . "Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study." BLOOD ADVANCES , vol.6, no.4, pp.1243-1254.
@article{article, author={Janet L. Kwiatkowski Et Al. }, title={Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study}, journal={BLOOD ADVANCES}, year=2022, pages={1243-1254} }